Ibn Ansari, DPM
Foot & Ankle Surgery · Orangeburg, SCNPI 1346777927
Payments from drug & device makers
What this record shows
This record is dominated by travel and lodging: $2,678 of the $4,017 with a category attached, or 66.7%. 17 manufacturers reported payments, led by Stryker at 39.9% of the total.
Across 50 payments — averaging $80.35 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Stryker$2K
- Paragon 28, Inc.$1K
- Treace Medical Concepts, Inc.$524
- Triad Life Sciences Inc.$169
- Smith+Nephew$57
- Amgen$57
- plus $317 from 11 others
What the payments were for
- Travel & lodging$2,67867%
- Food & beverage$1,33933%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Stryker | 18 | $1,604 |
| Paragon 28, Inc. | 3 | $1,289 |
| Treace Medical Concepts, Inc. | 6 | $524 |
| Triad Life Sciences Inc. | 2 | $169 |
| Smith+Nephew | 2 | $57 |
| Amgen | 2 | $57 |
| Organogenesis Inc. | 2 | $56 |
| Cashflow Solutions, LLC | 4 | $49 |
| AbbVie | 2 | $45 |
| GSK | 1 | $30 |
| Kowa Pharmaceuticals America, Inc. | 2 | $29 |
| Kerecis Limited | 1 | $23 |
| Fidia Pharma USA Inc. | 1 | $22 |
| Nabriva Therapeutics, PLC | 1 | $20 |
| Heron Therapeutics, Inc. | 1 | $17 |
| Integra Lifesciences Corporation | 1 | $15 |
| Medela LLC | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Portfolio$1,262
- PROstep$1,050
- Lapiplasty System$340
- InnovaMatrix AC$153
- ORTHOLOC 2 LAPIFUSE$129
How this compares
$4,017 in reported general payments places this provider in the 55th percentile of 87 foot & ankle surgery providers in South Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Clotrimazole | 45 | $1,260 |
| Ketoconazole | 46 | $904 |
| Diclofenac Sodium | 23 | $542 |
| Lidocaine-PrilocaineLidocaine/Prilocaine | 25 | $483 |
| Ciclopirox | 12 | $319 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 15 | $212 |
| CiclopiroxCiclopirox Olamine | 11 | $153 |
| Ibuprofen | 18 | $145 |
| Gabapentin | 14 | $143 |
| Meloxicam | 22 | $73 |
Paid to pharmacies, not to this prescriber.
Other foot & ankle surgery in Orangeburg
- Kevin RayOrangeburg$7K
- Sabina AbbasovaOrangeburg$5K
- Courtney BordenkecherOrangeburg$5K
- Christine RihnOrangeburg$2K
- Benjamin OverleyHilton Head Island$643K
- Tyler GonzalezColumbia$525K
- Alison GartenRock Hill$419K
- Christopher GrossCharleston$394K
- Robert KleinGreenville$358K
- William JamesColumbia$222K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.